CLINICAL ROLE -
Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
Study: New Tools Aid Development of Drugs for Respiratory Syncytial Virus
Tools provide a safer testing option without using the viral proteins that cause infection.
Read More
Data Show Disadvantaged Groups Have Significant Need for Lung Cancer Screening
Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.
FDA Grants Priority Review for Zanidatamab to Treat HER2-Positive Metastatic Biliary Tract Cancer
If approved, zanidatamab will be the first HER2-targeted treatment indicated for individuals with this type of biliary tract cancer.
Omega-3 Supplements Could Benefit Children’s Brain Development
Researchers aimed to explore impacts of omega-3 fatty acids on children’s behavior, mood, and sleep.
Study Finds Semaglutide Improves Chronic Kidney Disease in Patients With Type 2 Diabetes
The role of semaglutide as a glucagon-like peptide-1 (GLP-1) receptor antagonist could offer further treatment options to improve patient outcomes.
Study: Outcomes of RSV Associated with Acute Respiratory Failure
The results showed that during a 1-month hospital stay, 13% of individuals who experienced RSV-associated acute respiratory failure died.
Study Evaluates Use of Milvexian in Secondary Stroke Prevention
The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.
FDA Grants Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.
The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell Lung Cancer
Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.
Pharmacy Influencers Share How to Balance Passions and Career
Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.
FDA Ensures Safety and Effectiveness of Laboratory Developed Tests
Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.
FDA Grants Fast Track Designation for SNB-101 to Treat Small Cell Lung Cancer
SNB-101 is the first nanoparticle anticancer drug that was developed exceedingly insoluble SN-38 into polymer nanoparticles.
Officials Release Draft Legislation Aimed at Prescription Drug Shortage Issues
Ongoing and active shortages are currently at the highest number since January 2001.
Lung Cancer Action Week: How Individuals Can Aid the Fight Against Lung Cancer
Pharmacists can raise awareness for lung cancer during and after Lung Cancer Action Week.
US Preventive Services Task Force Recommends Breast Cancer Screenings Begin at Age 40
The screenings should be conducted every other year, beginning at age 40 and continuing through age 74, according to the new recommendation.
Study: Probiotic with Vitamin D Supplements Could Aid Individuals with Schizophrenia
Vitamin D deficiency (VDD) is an important factor in the pathogens of schizophrenia.
FDA Approves Trastuzumab Biosimilar to Treat Forms of HER2-Overexpressing Cancer
Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.
Study Highlights Reduced Disease Severity When Vaccinated Against RSV
The severity of RSV disease among adults further highlights how crucial vaccine polices and recommendations are.
Adjuvant Alectinib Could Aid Disease-Free Survival in ALK-Positive NSCLC
A 76% lower risk was displayed with adjuvant alectinib compared to chemotherapy treatment for non–small cell lung cancer.
Study: The Role of Vitamin A in Wound Repair
Retinoic acid, an active form of vitamin A, is crucial for the stem cells to depart lineage plasticity which get separated into hair cells or epidermal cells in vitro.
FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease
The primary endpoint of the study was clinical remission at week 52 with vedolizumab
Study: Chemotherapy to Treat Breast Cancer Increases Risk of Lung Cancer
Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.
RSV Vaccine Could Prevent Increased Risk of Disease Among Individuals Aged 18 to 59
The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety
FDA Grants Fast Track Designation for LYT-200 to Treat Head and Neck Cancers
Treatment with LYT-200 is currently being assessed in a phase 1/2 adaptive design trial in advanced/metastatic solid tumors and in a phase 1b clinical trial.
FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer
The designation was granted based on overall survival data from an ongoing randomized phase 2 clinical trial.
Durvalumab Shows Improvements in Overall Survival, Progression-Free Survival for Small Cell Lung Cancer
Both dual primary endpoints—progression-free survival and overall survival—were met with durvalumab.
Study: Blended Antioxidant Supplement Could Improve Age-Related Health Decline
Aged mice displayed improvements in their spatial cognition, short-term memory, and muscle durability.
Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer
Study outcomes demonstrated that 80 HER2-postive BTC individuals enrolled in Cohort 1 of the study achieved a confirmed objective response rate of 41.3%
Adagrasib Meets Primary Endpoint Among Individuals with KRAS G12C-Mutated Locally Advanced or Metastatic NSCLC
The positive results in both progression-free survival and overall response rate were endorsed in a confirmatory study.
Behavioral Interventions Give Hope for Management of Insomnia Beyond the Sleep Specialist’s Office
Stephanie Ashraf, MD, offered clinical experience in managing insomnia at the American Medical Women’s Association (AMWA) 2024 Annual Meeting.